Tag: anti-SARS-CoV-2 plasma product
CSL Behring Australia Commences Development of Treatment for Serious Cases of COVID-19
Media Release
CSL Behring Australia, a subsidiary of CSL Limited, today announced that it will begin immediate onshore development of an anti-SARS-CoV-2 plasma product with...
Featured Article
Circular beds: Revolutionising sustainable bedding in Australia
A new wave of innovation is transforming the Australian manufacturing sector, with sustainability at its core. ROBOVOID, in collaboration with Swinburne University, GT Recycling, and Sustainability Victoria, has developed a groundbreaking bed base made entirely from recycled plastic.
